Identifying TRIM11 Upregulators as Therapeutic Targets in Alzheimer's Disease: A Bayesian Network Approach

Area of Science:

• Neuroscience
• Genetics
• Computational Biology

Background:

• Alzheimer's Disease (AD) is characterized by the downregulation of TRIM11.
• Overexpression of TRIM11 has shown potential in improving cognitive function in AD mouse models.

Purpose of the Study:

• To identify potential genetic regulators of TRIM11 using advanced computational methods.
• To explore regulatory networks influencing TRIM11 expression in the context of Alzheimer's Disease.

Main Methods:

• Utilized single-cell and single-nucleus RNA sequencing on publicly available datasets (GSE173731, GSE227222).
• Employed a probabilistic approach and Bayesian networks to identify gene regulatory relationships.
• Applied graph learning methods for network analysis.

Main Results:

• Identified a set of candidate genes potentially regulating TRIM11 expression in both analyzed datasets.
• The identified genes suggest novel regulatory pathways influencing TRIM11 in Alzheimer's Disease.

Conclusions:

• The study provides potential genetic targets for modulating TRIM11 activity.
• These findings offer promising avenues for developing future therapeutic strategies for Alzheimer's Disease.